Anna was Chief Medical Officer at 2Seventy Bio, and Vice President, Clinical Development and Medical Affairs Oncology at Genetix Biotherapeutics. Anna Truppel-Hartmann joined KSQ Therapeutics in 2024.
Anna Truppel-Hartmann is currently
Create your alert
to follow the career of Anna Truppel-Hartmann.
Anna Truppel-Hartmann has a Doctor of Medicine from University of Zurich.
They have also studied at University of Zurich :
Find more alumni from University of Zurich
Do you need to know more about Anna Truppel-Hartmann? More results.
Report an error
Update the org chart details of Anna Truppel-Hartmann.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.